Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogrammingJia Liu, Huai‐Qiang Ju, Zexian Liu et al.|Nature Communications|2020Cited by 258
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trialFeng Wang, Rui‐Hua Xu, Xiaohua Hu et al.|Nature Medicine|2024Cited by 162
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratioXiaoli Wei, Rui‐Hua Xu, Feng‐Hua Wang et al.|BMC Cancer|2015Cited by 160
Association of Plasma Epstein-Barr Virus DNA With Outcomes for Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma Receiving Anti–Programmed Cell Death 1 ImmunotherapyJianying Xu, Feng‐Hua Wang, Xiaoli Wei et al.|JAMA Network Open|2022Cited by 64
A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumorsXiaoli Wei, Rui‐Hua Xu, Chao Ren et al.|Cancer Communications|2020Cited by 54